Funding for this research was provided by:
Veterinärmedizinische Universität Wien
Received: 3 February 2021
Accepted: 1 March 2021
First Online: 20 April 2021
Conflict of interest
: F. Roth-Walter is the main inventor of EP2894478 (applicant Biomedical International R+D GmbH, Vienna, Austria), the basis for the FSMP lozenge ImmunoBON®. F. Roth-Walter has been conducting clinical studies on this topic since 2017 and has received research funding from Biomedical International R+D GmbH, Vienna, Austria, Bencard Allergie GmbH, Munich, Germany and Vienna, Austria, and Allergy Therapeutics, Worthing, UK.